NM_000545.8:c.1803dupA
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_000545.8(HNF1A):c.1803dupA(p.Asp602ArgfsTer47) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★★).
Frequency
Consequence
NM_000545.8 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HNF1A | ENST00000257555.11 | c.1803dupA | p.Asp602ArgfsTer47 | frameshift_variant | Exon 10 of 10 | 1 | NM_000545.8 | ENSP00000257555.5 | ||
C12orf43 | ENST00000288757 | c.*3054dupT | 3_prime_UTR_variant | Exon 6 of 6 | 1 | NM_022895.3 | ENSP00000288757.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Monogenic diabetes Uncertain:1
The c.1803dupA variant in the HNF1 homeobox A gene, HNF1A, causes a frameshift in the protein at codon 602 (NM_000545.8), adding 47 novel amino acids before encountering a stop codon (p.(Asp602ArgefsTer47)). While this variant, located in exon 10 of 10, is not predicted to result in nonsense mediated decay of the transcript, it will significantly disrupt the transactivation domain of the protein (PVS1_Strong). Additionally, this variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in an individual with diabetes; however, the MODY probability is unable to be calculated due to lack of information about when insulin treatment was initiated, and HNF4A was not tested (internal lab contributors). Therefore, PP4 cannot be applied. In summary, c.1803dupA meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/21): PVS1_Strong, PM2_Supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.